July 2024 – Page 11 – Goldea Capital

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

― On track to report topline data for Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) by the end of October 2024 ― ― Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ― ― Conference call and webcast scheduled for 8:00 a.m. ET today ― CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today reported financial results for the second quarter of 2024 as well as a business update. “We are on track to report topline results for the Phase 3 REACH trial by the end of October 2024, and as we advance towards this important...

Lantheus Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully diluted earnings per share of $1.80 compared to $1.54 in the second quarter 2023, reflective of inter-quarter investment in business development and R&D. The Company maintains full year 2024 revenue guidance and updates fully diluted earnings per share guidance driven by strategic transactions BEDFORD, Mass., July 31, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes,...

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

— Cash Position of $307 Million Provides Stable and Strong Capital Foundation –— Total Net Revenue of $68 Million ($124 Million Year-To-Date) Reflecting Continuing Efforts to Maximize VASCEPA/VAZKEPA Performance Globally — — Leadership Transition Completed with Appointment of Aaron Berg as President and CEO — DUBLIN and BRIDGEWATER, N.J., July 31, 2024 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today reported financial results for the second quarter ended June 30, 2024, and provided a business update. Commenting on the Company, Aaron Berg, Amarin’s President and CEO, said, “As I begin in my new role as CEO of Amarin, my focus is clear: drive value by focusing on operational execution and performance while urgently evaluating opportunities to expand the impact of VASCEPA/VAZKEPA to benefit...

Macerich Reports Second Quarter 2024 Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

SANTA MONICA, Calif., July 31, 2024 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its Second Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at www.macerich.com. As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Wednesday, July 31, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in number and a personalized PIN code that will be required to access the call. Participants may join the live webcast by accessing it at the webcast registration link below or in the Investors Section of the company’s website at https://investing.macerich.com/. Dial-In Registration:...

Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023 Gross profit of $249.4 million, or 20.3% of net revenue, down 0.6% compared to $250.8 million, or 23.5% of net revenue, in the second quarter of 2023 Net income of $53.0 million, or $0.30 diluted earnings per share, down 53.6% compared to net income of $114.4 million, or $0.63 diluted earnings per share, in the second quarter of 2023 Adjusted EBITDA of $108.4 million, down 1.5% compared...

The Chefs’ Warehouse Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

RIDGEFIELD, Conn., July 31, 2024 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its second quarter ended June 28, 2024. Financial highlights for the second quarter of 2024: Net sales increased 8.3% to $954.7 million for the second quarter of 2024 from $881.8 million for the second quarter of 2023. GAAP net income was $15.5 million, or $0.37 per diluted share, for the second quarter of 2024 compared to $9.9 million, or $0.25 per diluted share, in the second quarter of 2023. Adjusted net income per share1 was $0.40 for the second quarter of 2024 compared to $0.35 for the second quarter of 2023. Adjusted EBITDA1 was $56.2 million for the second quarter...

First National Corporation Reports Second Quarter Financial Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

STRASBURG, Va., July 31, 2024 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), reported unaudited consolidated net income of $2.4 million and basic and diluted earnings per common share of $0.39 for the second quarter of 2024 and adjusted net income(1) of $3.0 million and adjusted basic and diluted earnings per common share(1) of $0.48. (Dollars in thousands, except earnings per share) Three Months Ended Jun 30, 2024 Mar 31, 2024 Jun 30, 2023 Net income $ 2,442 $ 3,209 $ 3,505 Basic and diluted earnings per share $ 0.39 $ 0.51 $ 0.56 Return on average assets 0.68 % 0.90 % 1.02 % Return on average equity 8.31 % 11.07 % 12.56 % Non-GAAP Measures: Adjusted...

ScottsMiracle-Gro Reports Fiscal 2024 Third Quarter Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

U.S. Consumer third quarter net sales of $1 billion exceed prior year by 11 percent; Consumer engagement shows strength with unit POS up 10 percent year-to-date Third quarter GAAP gross margin rate of 29.5 percent improves 1,110 bps over prior year; Non-GAAP adjusted gross margin rate of 29.2 percent improves 790 bps Hawthorne proprietary Signature sales increase 6 percent in Q3 Third quarter 2024 GAAP EPS of $2.28; Non-GAAP Adjusted EPS of $2.31 nearly doubles third quarter 2023 non-GAAP result MARYSVILLE, Ohio, July 31, 2024 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s largest marketer of branded consumer lawn and garden as well as a leader in indoor and hydroponic growing products, today announced its results for the third quarter ended June 29, 2024. “Despite a sluggish start to the lawn and...

The Vita Coco Company Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

Net Sales Increased 3% to $144 million with Vita Coco Coconut Water Growth of 4% Net Income Increased $1 million to $19 million and Non-GAAP Adjusted EBITDA1 Increased $8 million to $32 million Circana US scan data MULO+C, Vita Coco Coconut Water grew 14% Company Reaffirms Full Year Guidance Expects Net Revenue between $500-$510 million and Adjusted EBITDA2 between $76-$82 million NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the second quarter ended June 30, 2024. Second Quarter and Year-To-Date 2024 Highlights Net sales grew 3% in the second quarter to $144 million and 3% year-to-date to $256 million. Vita Coco Coconut Water net sales growth of 4% in the...

Dayforce Reports Second Quarter 2024 Results¹

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

Dayforce® recurring revenue of $321.6 million, up 20% Total revenue of $423.3 million, up 16% Year-to-date net cash provided by operating activities of $108.3 million, up 16% MINNEAPOLIS and TORONTO, July 31, 2024 (GLOBE NEWSWIRE) — Dayforce, Inc. (“Dayforce” or the “Company”) (NYSE:DAY) (TSX:DAY), a global leader in human capital management (“HCM”) technology, today announced its financial results for the second quarter ended June 30, 2024. “Our business momentum continued in the second quarter of 2024, with Dayforce recurring revenue up 20%, and year-to-date cash flows from operating activities up 16%. Our success is rooted in the simplicity that organizations around the world are seeing with the Dayforce platform, enabling them to create significant efficiencies in their businesses while delivering...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice